With the maturation and application of genetic engineering technology, it is now possible to design, modify, and express proteins as needed, leading to a diverse array of recombinant proteins.

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia ™ assay portfolio with the launch of its Tagged Protein ...

Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia's applications across recombinant protein research, ...